Pharmaceutical

Influenza (quadrivalent) vaccine by Pfizer for Influenzavirus A Infections: Likelihood of Approval

Influenza (quadrivalent) vaccine is under clinical development by Pfizer and currently in Phase III for Influenzavirus A Infections.

May 17, 2024 - 04:00
Influenza (quadrivalent) vaccine is under clinical development by Pfizer and currently in Phase III for Influenzavirus A Infections.
Read the original article

Tags:

Previous Article

Influenza (quadrivalent) vaccine by Pfizer for Influenzavirus B Infections: Like...

Next Article

TT-01488 by TransThera Sciences (Nanjing) for Mantle Cell Lymphoma: Likelihood o...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Alnylam abandons plans for RNAi drug Onpattro after FDA hits the brakes

Alnylam abandons plans for RNAi drug Onpattro after FDA...

Oct 9, 2023

Opinion: Contact sports cause CTE. So why are Americans watching more football than ever?

Opinion: Contact sports cause CTE. So why are Americans...

Feb 9, 2024

STAT+: Key senators blast Medicare Advantage insurers for ‘exorbitant salaries,’ ‘massive payouts’ to execs

STAT+: Key senators blast Medicare Advantage insurers f...

Mar 24, 2023